High materiality9/10
Lucid Capital Markets Starts Adial Pharmaceuticals Inc (ADIL) at Buy
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Loop Capital Markets initiated ADIL with a Buy rating; Target is $6 while the current price is $2.98.
- Loop Capital initiates ADIL with Buy; Target $6; Price $2.98.
Key facts
- 01
Target: $6
- 02
Posted price: $2.98
- 03
Analyst firm: Loop Capital Markets
- 04
Analyst: Elemer Piros
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.